{"identifier":"nobleid:/w1/20260521/9DAE0EE9","arkIdentifier":"ark:/48914/w1/20260521/9DAE0EE9","version":1,"workTitle":"P09.53 Comparative Effectiveness of Crizotinib versus Entrectinib in ROS1+ Non-Small Cell Lung Cancer (NSCLC) using Clinical Trial and Real-World Data","workType":"Journal Article","authors":"M. Groff, Gabriel Tremblay, Laura Iadeluca, K. Wilner, Robin Wiltshire, Lauren Bartolome, Tiziana Usari, J.C. Cappelleri, D. Ross Camidge","description":null,"workUrl":null,"existingDoi":"10.1016/j.jtho.2021.01.481","createdAt":"2026-05-21T13:23:12.341255Z","canonicalUrl":"https://nobleid.org/ark:/48914/w1/20260521/9DAE0EE9.v1"}